Method and device for immunoassay using nucleotide conjugates

• US 9,964,537 B2
• Filed: 10/30/2015
• Issued: 05/08/2018
• Est. Priority Date: 12/31/2008
• Status: Active Grant

• Current Assignee: Abbott Point Of Care Incorporated (Abbott Laboratories Incorporated)
• Original Assignee: Abbott Point Of Care Incorporated (Abbott Laboratories Incorporated)
• Inventors: Collier, G. Bruce, Miller, Cary James
• Primary Examiner(s): Brown, Melanie Yu
• Application Number:
  US14/928,418
• Publication Number:
  US 20160047800A1
• Time in Patent Office: 921 Days
• CPC Class Codes: G01N 2458/10 Oligonucleotides as tagging agents for labelling antibodies
• CPC Class Codes: G01N 33/5302 Apparatus specially adapted for immunological test procedures
• CPC Class Codes: G01N 33/5306 Improving reaction conditions, e.g. reduction of non-specific binding, promotion of specific binding
• CPC Class Codes: G01N 33/58 involving labelled substances G01N33/53 takes precedence
• CPC Class Codes: G01N 33/6887 from muscle, cartilage or connective tissue

Abstract

A composition of matter for use in an immunoassay devices and method comprising a signal antibody, e.g., FAB fragment, covalently linked to a first nucleotide; and one or more signal elements, e.g., signal enzymes such as ALP or fluorescent dyes, each covalently linked to a second nucleotide, wherein the first nucleotide has one or more repeated sequences, and the second nucleotide is bound to one of the one or more repeated sequences on said first nucleotide, and wherein the ratio of the signal antibody to the signal element is controlled by the number of repeated sequences.

Claims

1. A method of determining the presence of an analyte in a blood sample comprising:

contacting the blood sample with a first antibody such that the first antibody becomes solubilized in the blood sample and binds to the analyte, wherein the first antibody is bounded to at least one signal enzyme via a synthetic nucleotide bridge comprising a first single stranded nucleotide and second single stranded nucleotide;

contacting the blood sample comprising the solubilized first antibody and the antigen with an immobilized second antibody such that the immobilized second antibody binds to the antigen to form an immunoassay;

washing the blood sample from the immunoassay; and

determining the presence of the analyte based on a signal generated by a reaction with the at least one signal enzyme,

wherein a 3′

-end or 5′

-end of the a first single stranded nucleotide and the a second single stranded nucleotide is protected from endogenous exonuclease activity from said blood sample contacting said second antibody by incorporating a protective chemical group.

2. The method of claim 1, wherein the at least one signal enzyme is selected from the group consisting of alkaline phosphatase, glucose oxidase, lactate oxidase, urease, horseradish peroxidase, galactose oxidase, and beta-galactosidase.

3. The method of claim 1, wherein the first antibody binds to a first epitope of the analyte.

4. The method of claim 3, wherein the second antibody binds to a second epitope of the analyte.

5. The method of claim 1, wherein the at least one signal enzyme is a plurality of signal enzymes in the range of about 10 to about 100.

6. The method of claim 5, wherein the first antibody is one of a plurality of signal conjugates and at least 50 wt. % of the plurality of signal conjugates have the plurality of signal enzymes in the range of about 10 to about 100.

7. The method of claim 1, wherein the at least one signal enzyme is a plurality of signal enzymes comprising at least two different types of enzymes.

8. The method of claim 1, wherein the first antibody is immobilized to a carboxyl derivatized polystyrene bead.

9. The method of claim 1, wherein the protective chemical group is a phosphorothioate.